Bridging Chemotherapy: Relapsed/Refractory Aggressive B-Cell Lymphoma
Crossref DOI link: https://doi.org/10.1007/978-3-030-94353-0_22
Published Online: 2022-02-07
Published Print: 2022
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thieblemont, Catherine
Borchmann, Peter
Funding for this research was provided by:
European Society for Blood and Marrow Transplantation
The European Hematology Association
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-02-07
Chapter History
First Online: 7 February 2022